Hepatic Histopathology in Urea Cycle Disorders

计划入组 70 人 · 首次发布于 2021 年 6 月 1 日

Longitudinal Study of Urea Cycle Disorders

计划入组 1,500 人 · 首次发布于 2005 年 10 月 12 日

Chemotherapy Toxicity Reduction Via Urea Cycle Support

计划入组 100 人 · 首次发布于 2005 年 9 月 22 日

Urea cycle disorders(CAMP4 Therapeutics)

RNA actuator therapeutic (urea cycle disorder)

Glycerol phenylbutyrate(Ravicti)

C₃₃H₃₈O₆ · Rx

Zevra Therapeutics

United States

CYCLE PHARMACEUTICALS LTD

United Kingdom

Cycle Pharmaceuticals Ltd.

United States

Citrin Foundation and University Children's Hospital Zürich Launch Pioneering Center for Urea Cycle Disorders Research

Ravicti Receives Regulatory Approval in Saudi Arabia, Qatar, and Kuwait for Urea Cycle Disorders

Endo Launches First Generic Version of RAVICTI for Rare Urea Cycle Disorders